Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer
{{output}}
Background: Doxorubicin (DOX)-based chemotherapy has improved survival outcomes in breast cancer patients but is often limited by doxorubicin-induced cardiotoxicity (DIC). Currently, no validated biomarkers can predict early DIC.... ...
